Medical facilities and medications are now urgently needed as a result of the COVID-19 outbreak. By offering the necessities, India’s pharmaceutical industry is also expanding and improving people’s lives. Let us see some of the top pharma companies in India today.
The financial year 2020 saw $4.7 billion in revenue for Sun Pharmaceutical Industries. In India, it is the top multinational pharmaceutical company. The year 1983 saw the founding of Sun Pharma. Mr Dilip Shanghvi, who also serves as Sun Pharmaceuticals’ MD, founded it. In order to cure psychiatric conditions, the company started selling items. The company now also provides formulations in various medicinal, gastrointestinal, and diabetology fields.
According to overall sales, Sun Pharmaceutical Industries is one of the most prominent pharma companies in India. It ranks as the fourth-largest speciality generic pharmaceutical firm worldwide. Along with anti-cancer medications, steroids, peptides, sex hormones, and prohibited substances, it also sells the drugs carbamazepine, etodolac, and clorazepate. Alkaloids Chemical Company Zrt, Sun Petrochemical Pvt. Ltd, Sun Ophthalmic Inc, Ranbaxy Laboratories, and Chattem Chemicals are some of its subsidiaries.
An international pharmaceutical corporation with headquarters in Hyderabad, India is called Divi’s Laboratories Limited. 1990 saw the founding of Divi’s Laboratories which today stands as one of the top pharma companies in India. Active pharmaceutical ingredients (APIs) and intermediates are produced by Divi’s Laboratories Ltd. This Indian pharmaceutical company produces premier generic chemicals, Nutraceutical components, specially formulated APIs, and intermediates for leading international innovator firms. With $780 million in projected sales for 2020 and exports to more than 95 nations, Divi’s Laboratories is one of the biggest API businesses in the world.
In 1984, Anji Reddy established Dr Reddy’s Laboratories. A multinational pharmaceutical corporation based in India. In India and beyond, it is renowned for producing a huge variety of medications. They offer more than 190 drugs, and 60 pharmaceutical active components for use in drug production, diagnostic tools, critical care supplies, and biotechnology items. It generates US$2.4 billion in revenue each year and is the fifth-largest pharmaceutical firm in India. Canagliflozin, Ibuprofen, Ramipril, Naproxen, Nizatidine, Atorvastatin, Naproxen Sodium, and others are some of Dr Reddy’s well-known medications.
Khwaja Abdul Hamied founded Cipla, a multinational pharmaceutical and biotechnology corporation with its headquarters in Mumbai, in 1935. Cipla’s Non-Executive Chairman is Yusuf Hamied. It ranks as the fourth-largest pharmaceutical company in India in terms of overall sales. This Indian pharmaceutical firm focuses on creating drugs to address conditions like asthma, cardiovascular disease, arthritis, diabetes, weight loss, depression, and many more.
With more than 22,036 people, Cipla will generate $2.5 billion in revenue in 2020; undoubtedly one of the largest pharma companies in India. Invagen Pharmaceuticals is one of Cipla’s subsidiaries. They produce the most antiretroviral medications of any company.
Satish Ramanlal Mehta established the Emcure Pharmaceuticals business in Pune in 1983. Emcure Pharmaceuticals was established in order to realise the vision of meeting the enormous healthcare requirements. Emcure Pharmaceuticals began as a lone manufacturing facility in Pune and expanded steadily over the years, eventually amassing a number of top-notch manufacturing facilities for API, formulations, and biotechnology. Emcure is today recognised as a vertically integrated pharmaceutical company with noteworthy resources, abilities, and infrastructure that is not only equivalent to the top pharmaceutical firms in Mumbai, India, but also to those that are regarded as the best in the world. Emcure’s key competitive advantages are its manufacturing of APIs, formulations, and biotechnology making it one of the distinctive.
One of the most well-known pharma companies in India is Biocon, which was established in 1978. Generic active medications are produced by Biocon Limited. Bengaluru serves as the company’s headquarters. Products from Biocon Limited are sold on a massive scale all over the world. The company, which employs over 9000 people, has sales of $659.31 million (INR 4,885 crores) in FY20 and total assets worth over $824 million.
One of the top pharma companies in India is Torrent. Its headquarters are in Ahmedabad, and as of 2020, it generated US$1.1 billion in revenue. Torrent has manufacturing facilities in Madhya Pradesh, Gujarat, Pithampur, and Dahej. Torrent Pharma produces pharmaceuticals for the anti-infective, digestive pain treatment, gastrointestinal diabetology, and Central Nervous System (CNS) segments.
One of the top pharma companies in India Lupin is headquartered in Mumbai. Desh Bandhu Gupta launched Lupin in 1968. A well-known pharmaceutical maker in India, it is the 12th-largest firm in terms of market capitalisation. In 2020, Lupin will earn $2.2 billion in revenue. Pediatric, cardiovascular, anti-infectives, diabetology, asthma, and anti-tuberculosis medications are among the drugs the company manufactures and sells.
Major markets for Lupin Limited include the United States (Baltimore, Maryland), Europe, India Region Formulations, Japan, Australia, South Africa, the Philippines, and Latin America, among others. A few of Lupin Ltd.’s subsidiaries include Kyowa Pharmaceutical Industry Co. Ltd. and Lupin Pharmaceutical Inc.
The 1952 founding year of Cadila Healthcare Limited. Zydus Cadila is another name for it. It is an Indian pharmaceutical corporation with its main office in Ahmedabad. With a revenue of US$2.1 billion in 2021, it is one of the biggest pharmaceutical businesses in India.
Along with producing herbal, skincare, and other OTC items, Cadila Healthcare Limited is renowned for providing superior diagnostics. Based on the voluntary licence agreement with Gilead, the business additionally produces generic drugs for the treatment of hepatitis C. Three facilities in India—the Ankleshwar plant, the Vadodara plant, and the Patalganga facility—manufacture API for Cadila.